Perioperative medicine & outcomes

Risk of Venous Thromboembolism After Total Knee Arthroplasty in Patients with Obstructive Sleep Apnea: Results from a National Cohort

Anesth AnalgPublished Retrospective cohort study

Main finding · DVT/PEResult — go to the resultOdds ratio 1.19 CI 1.1–1.3

Authors' conclusion

In this study encompassing a nationally representative sample of TKA patients, OSA was associated with increased incidence of VTE at 1 month postoperatively, an association that persisted after the generation of matched cohorts.

Study context

Population
US adults undergoing total knee arthroplasty (TKA), January 1, 2013 to January 1, 2023underwent TKA
Participants
197,460 adults
Exposure
Preexisting obstructive sleep apnea (OSA) vs no OSA
  • OSAn = 27,976
  • No OSAn = 150,830reference
Outcome
Venous thromboembolism (VTE):
  • DVT
  • PE
Follow-up
1 month postoperatively
Methodological details1:1 propensity score-matched, national database (TriNetX)
  • 1:1 propensity score-matched
  • National database (TriNetX)

Main finding

DVT/PE · 1 month

Odds ratio

1.19

CI 1.1–1.3

P < 0.001

OSA vs No OSA
OR 1.19 (CI 1.1–1.3); P < 0.001

As reported in the abstract

Observational data: associations, not effects.

Secondary outcomes

OutcomeOR (CI)P value
DVT · 1 monthPropensity score matched cohorts1.11 (1.0–1.2)P = 0.030
PE · 1 monthPropensity score matched cohorts1.41 (1.2–1.6)P < 0.001

Unmatched analysis: Deep vein thrombosis (DVT)/pulmonary embolism (PE), cerebrovascular accident (CVA), myocardial infarction (MI), DVT and PE · 1 month

OSA significantly associated with primary and all secondary outcomes in the initial analysis

Original publication

Risk of Venous Thromboembolism After Total Knee Arthroplasty in Patients with Obstructive Sleep Apnea: Results from a National Cohort. Anesth Analg. Published 15 August 2025. doi:10.1213/ane.0000000000007167

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.